BioCentury
ARTICLE | Company News

ArQule, University of California deal

July 7, 1997 7:00 AM UTC

The parties will collaborate on the discovery and design of protease inhibitors, initially targeting Kaposi's sarcoma, herpes virus, a Chagas disease protease called cruzain, and HIV. ARQL will asses...